17-AAG (Tanespimycin)

Catalog No.S1141

17-AAG (Tanespimycin) is a potent HSP90 inhibitor with IC50 of 5 nM in a cell-free assay, having a 100-fold higher binding affinity for HSP90 derived from tumour cells than HSP90 from normal cells. Phase 2.

Price Stock Quantity  
USD 195 In stock
USD 150 In stock
USD 370 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

17-AAG (Tanespimycin) Chemical Structure

17-AAG (Tanespimycin) Chemical Structure
Molecular Weight: 585.69

Validation & Quality Control

7 customer reviews :

Quality Control & MSDS

Related Compound Libraries

17-AAG (Tanespimycin) is available in the following compound libraries:

HSP (e.g. HSP90) Inhibitors with Unique Features

  • Selective HSP90 Inhibitor

    NVP-BEP800 HSP90β-selective, IC50=58 nM.

  • Most Potent HSP90 Inhibitor

    KW-2478 HSP90, IC50=3.8 nM.

  • HSP90 Inhibitor in Clinical Trial

    17-DMAG (Alvespimycin) HCl Phase II for Kidney Cancer.

  • Newest HSP90 Inhibitor

    XL888 ATP-competitive inhibitor of HSP90 with IC50 of 24 nM.

Product Information

  • Compare HSP (e.g. HSP90) Inhibitors
    Compare HSP (e.g. HSP90) Products
  • Research Area

Product Description

Biological Activity

Description 17-AAG (Tanespimycin) is a potent HSP90 inhibitor with IC50 of 5 nM in a cell-free assay, having a 100-fold higher binding affinity for HSP90 derived from tumour cells than HSP90 from normal cells. Phase 2.
Targets HSP90 [1]
(Cell-free assay)
IC50 5 nM
In vitro 17-AAG, an analog of geldanamycin, exhibits greater than 100 times higher binding affinity for Hsp90 derived from HER-2-overexpressing cancer cells (BT474, N87, SKOV3 and SKBR3) or BT474 breast carcinoma cells with IC50 values of 5-6 nM. [1] 17-AAG causes the degradation of HER2, HER3, Akt, and both mutant and wild-type androgen receptor (AR), leading to the RB-dependent G1 growth arrest of prostate cancer cells such as LNCaP, LAPC-4, DU-145, and PC-3 with IC50 values of 25-45 nM. [2] In addition to inducing apoptosis of Ba/F3 cells transformed with wild-type BCR-ABL with an IC50 of 5.2 μM, 17-AAG has the ability to induce apoptosis of cells transformed with imatinib mesylate-resistant T315I and E255K BCR-ABL mutants with IC50 values of 2.3 μM and 1.0 μM, respectively, by inducing the degradation of both wild-type BCR-ABL protein and mutants. [3]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
A549NVvCbXZtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4LPbWlEPTB;MD6wNFA{ODNizszNM2rYOXNCVkeHUh?=
IST-MEL1Ml;rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEfQN2tKSzVyPUCuNFAxPDB5IN88US=>NEG5bpZUSU6JRWK=
NCI-SNU-1M3vacmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYTJR|UxRTBwMECyNFch|ryPNFjBeFNUSU6JRWK=
FADUM364[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUjKVVRRUUN3ME2wMlAxOjB7IN88US=>MmnCV2FPT0WU
C32MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUTJR|UxRTBwMECzNFQh|ryPNF7nWldUSU6JRWK=
D-566MGMmXUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUnpWnhCUUN3ME2wMlAxOzlizszNMmjNV2FPT0WU
LXF-289MoL0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlvTTWM2OD1yLkCwOFE6KM7:TR?=NYqxO3BsW0GQR1XS
HGC-27M3TLemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX7JR|UxRTBwMEC1NUDPxE1?MkXrV2FPT0WU
RPMI-7951MlPMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mom1TWM2OD1yLkCwO|E4KM7:TR?=NFHOcpJUSU6JRWK=
HSC-3NIfOUVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX\JR|UxRTBwMEC5Nlkh|ryPMXzTRW5ITVJ?
MIA-PaCa-2NGHydIZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1\ENmlEPTB;MD6wNVAxQSEQvF2=NXTo[o9CW0GQR1XS
KS-1M2\nU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{HPcmlEPTB;MD6wNVM2PSEQvF2=NGHjRpdUSU6JRWK=
CAL-51NGDw[nRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUHl[pl{UUN3ME2wMlAyPDB3IN88US=>NHPpVZJUSU6JRWK=
MDA-MB-361MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWrNOlJ7UUN3ME2wMlAyPDl3IN88US=>NIPB[pVUSU6JRWK=
TI-73MlLGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX3zVJUzUUN3ME2wMlAyPzl4IN88US=>NVX6NmhlW0GQR1XS
AGSMlW4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHvjVllKSzVyPUCuNFE6OzhizszNMmTtV2FPT0WU
NCI-H460M2fI[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MofyTWM2OD1yLkCxPVc1KM7:TR?=Mn7lV2FPT0WU
A204NUDNfoh1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYrJR|UxRTBwMEKyOFkh|ryPMXzTRW5ITVJ?
CHL-1MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1\5d2lEPTB;MD6wNlI2OSEQvF2=MUTTRW5ITVJ?
DU-4475MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MW\JR|UxRTBwMEKyOlEh|ryPNGj0UHBUSU6JRWK=
CGTH-W-1MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWrJR|UxRTBwMEKzOFkh|ryPMmfkV2FPT0WU
HCC2218NH36SGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M13PN2lEPTB;MD6wNlQ6PCEQvF2=NV7jdoNJW0GQR1XS
A2780MoXMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX7FT2VyUUN3ME2wMlAzPTNzIN88US=>NGLhSVVUSU6JRWK=
NCI-H720NHTPeXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYOybZE2UUN3ME2wMlAzPTR4IN88US=>M4j2dnNCVkeHUh?=
NCI-N87MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4nVe2lEPTB;MD6wNlU6OyEQvF2=NYTYVWI6W0GQR1XS
CHP-212NF7UTYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWLJR|UxRTBwMEK2Nlgh|ryPNHHUepFUSU6JRWK=
NCI-H23M2XydWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmD5TWM2OD1yLkCyOlY2KM7:TR?=M2j2S3NCVkeHUh?=
D-263MGM1HEVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH3NT3pKSzVyPUCuNFI4QDZizszNNWPoVW9sW0GQR1XS
ME-180NYDkeWdPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mni4TWM2OD1yLkCyPFkyKM7:TR?=MkHOV2FPT0WU
SW982MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVKw[Y4{UUN3ME2wMlAzQTl7IN88US=>M17NcXNCVkeHUh?=
OE19NF\2Z4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1vab2lEPTB;MD6wN|A4PyEQvF2=NGrvN5JUSU6JRWK=
SK-LU-1NWTh[4F4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWTJR|UxRTBwMEOwPFIh|ryPMWPTRW5ITVJ?
H4MoTBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVjJR|UxRTBwMEOwPUDPxE1?NUTTeIZyW0GQR1XS
HT-144NETpbmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWTkWohoUUN3ME2wMlA{ODl|IN88US=>Mnq3V2FPT0WU
SK-UT-1NUT6fmk3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYTmNpE1UUN3ME2wMlA{OTd6IN88US=>NID0fmdUSU6JRWK=
D-336MGNIXjOo5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M320N2lEPTB;MD6wN|MxQSEQvF2=MonzV2FPT0WU
MDA-MB-175-VIINHLlfFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1:3cGlEPTB;MD6wN|M2PCEQvF2=NVexXlBDW0GQR1XS
GAMGNGfD[|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFT0XFNKSzVyPUCuNFM1OzVizszNNY\EeoZOW0GQR1XS
CP50-MEL-BMnjFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{XRU2lEPTB;MD6wN|Q2KM7:TR?=Mly1V2FPT0WU
OVCAR-5MkDOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MorhTWM2OD1yLkCzOFgh|ryPMmnZV2FPT0WU
SK-MES-1M{THXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXXJR|UxRTBwMEO2NFYh|ryPNFHod49USU6JRWK=
VM-CUB-1MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4jadWlEPTB;MD6wN|Y2PyEQvF2=NH;TfYlUSU6JRWK=
WM-115MkHyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXnJR|UxRTBwMEO3OlIh|ryPMnvwV2FPT0WU
DSH1MmfsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4HhcmlEPTB;MD6wN|gxPyEQvF2=MVLTRW5ITVJ?
BeckerMmP1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGLTVGNKSzVyPUCuNFM5QDVizszNNXzqe|RtW0GQR1XS
SW962NETaZ3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnHETWM2OD1yLkCzPVQ2KM7:TR?=NX24VFNMW0GQR1XS
TYK-nuNVToT4R[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGriXFJKSzVyPUCuNFM6QDVizszNNXizclNlW0GQR1XS
HO-1-N-1NIHV[WJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHfmSmRKSzVyPUCuNFQxOjFizszNM2n1VXNCVkeHUh?=
T98GM3uwR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXXJR|UxRTBwMESxNFMh|ryPMWXTRW5ITVJ?
ACNNVjpeZU2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2P1dmlEPTB;MD6wOFE3OiEQvF2=NV\EeWFbW0GQR1XS
SW780MkjkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWHP[WVsUUN3ME2wMlA1OjB|IN88US=>NX;0U4Z{W0GQR1XS
Detroit562M1m2Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3TxUWlEPTB;MD6wOFI{QSEQvF2=M1e4VnNCVkeHUh?=
BB49-HNCMUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXXkdnpCUUN3ME2wMlA1OjR|IN88US=>MkL4V2FPT0WU
HNMnnPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXi0UGZmUUN3ME2wMlA1Ojd{IN88US=>MUPTRW5ITVJ?
H9MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUDJR|UxRTBwMESzO|Eh|ryPMYTTRW5ITVJ?
VA-ES-BJM{n4R2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{DSN2lEPTB;MD6wOFQ1PyEQvF2=NYLKWI97W0GQR1XS
MEL-JUSONVy5b2hNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIjJOYFKSzVyPUCuNFQ1PzVizszNNYDLcJVkW0GQR1XS
BT-474M1e2cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVLDe4NMUUN3ME2wMlA1PSEQvF2=MUjTRW5ITVJ?
CaR-1NIDpUVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkLSTWM2OD1yLkC0OVQ6KM7:TR?=M3PiU3NCVkeHUh?=
PSN1M2nHUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUTJR|UxRTBwMES2NFMh|ryPNE\IS|hUSU6JRWK=
KYSE-510NHnvVGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3O2RWlEPTB;MD6wOFY1QSEQvF2=NVnCXGFXW0GQR1XS
KP-4M4TVd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2DOe2lEPTB;MD6wOFc2OyEQvF2=M4rWOnNCVkeHUh?=
KYSE-410M1fHc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkfRTWM2OD1yLkC0O|czKM7:TR?=NYTaN2VLW0GQR1XS
G-402M{PQTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGW4UZVKSzVyPUCuNFQ4QDlizszNNFr6fnpUSU6JRWK=
DOKMl\qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXnJR|UxRTBwMES5NFIh|ryPNWPTXHJiW0GQR1XS
COR-L88NISyNIZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYrZR5dwUUN3ME2wMlA1QTF{IN88US=>NEDYSHBUSU6JRWK=
SKG-IIIaNXLTR5VCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFfXb2xKSzVyPUCuNFQ6QDZizszNMlzTV2FPT0WU
AN3-CAMlfBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXPxclY4UUN3ME2wMlA2KM7:TR?=M1vsSXNCVkeHUh?=
SW48Mn3kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYDSeGw6UUN3ME2wMlA2ODN7IN88US=>NWrBb5JxW0GQR1XS
YKG-1M{XRbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoDTTWM2OD1yLkC1NFcyKM7:TR?=MojzV2FPT0WU
KYSE-150MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXTpR5ZqUUN3ME2wMlA2OjN3IN88US=>M4PoTHNCVkeHUh?=
HuO-3N1M3HySmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUfacoxuUUN3ME2wMlA2OjN5IN88US=>MmfEV2FPT0WU
LB1047-RCCMlKwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3jzXmlEPTB;MD6wOVI6PiEQvF2=M334NXNCVkeHUh?=
NCI-H2030M{DuW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUm4eW5TUUN3ME2wMlA2PDF2IN88US=>NFjUfHdUSU6JRWK=
YH-13NH\4eYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4\IfGlEPTB;MD6wOVczOiEQvF2=M161cXNCVkeHUh?=
5637M3v3fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYPqVpgxUUN3ME2wMlA2PzRizszNMYLTRW5ITVJ?
LOXIMVIMXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkOzTWM2OD1yLkC1PFczKM7:TR?=M1XGXnNCVkeHUh?=
GT3TKBNVHMb|kyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXXJR|UxRTBwMEW5OFIh|ryPNV7ZTm9VW0GQR1XS
TCCSUPNVnrdXFuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlXsTWM2OD1yLkC1PVY1KM7:TR?=MVnTRW5ITVJ?
EPLC-272HMlXQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWXXVmxFUUN3ME2wMlA3OjB3IN88US=>M4LPN3NCVkeHUh?=
LU-99AMWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUnVT|M2UUN3ME2wMlA3OjN5IN88US=>NEPzV3ZUSU6JRWK=
NCI-H1755M13T[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWfZTVBmUUN3ME2wMlA3OzRzIN88US=>MX;TRW5ITVJ?
KM12NYPlZWJiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX3JR|UxRTBwME[zOFgh|ryPNULJV2RsW0GQR1XS
SF295NGDUT|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmTuTWM2OD1yLkC2OFUzKM7:TR?=MXLTRW5ITVJ?
MZ2-MELNIn5cHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmPXTWM2OD1yLkC2OVU{KM7:TR?=MmHHV2FPT0WU
HEC-1Mmq5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2DvTWlEPTB;MD6wOlU5QCEQvF2=M4LnbnNCVkeHUh?=
SW684MnHaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3TPeWlEPTB;MD6wOlU6OSEQvF2=NHnETHBUSU6JRWK=
SF539MmXSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlrBTWM2OD1yLkC2OlgyKM7:TR?=M{XZcHNCVkeHUh?=
GMS-10NFnQOYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWLWfo0{UUN3ME2wMlA3Pjl7IN88US=>M3LmOXNCVkeHUh?=
MV-4-11MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX7JR|UxRTBwME[4NFMh|ryPMXHTRW5ITVJ?
HT-29NIrpfIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmC1TWM2OD1yLkC2PVE6KM7:TR?=NUP2N5BtW0GQR1XS
23132-87NYLnR4ZsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYLJR|UxRTBwME[5OUDPxE1?NX6xfYhlW0GQR1XS
SW620NEfYNplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFjEe3pKSzVyPUCuNFcxOjZizszNM1nLWnNCVkeHUh?=
HCC1806MnPwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYHJR|UxRTBwMEexN|Eh|ryPMUfTRW5ITVJ?
Hs-578-TM1z5TGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH7aO3VKSzVyPUCuNFczODhizszNM2jXTXNCVkeHUh?=
A2058MnvQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEfhdodKSzVyPUCuNFczOjhizszNMX7TRW5ITVJ?
MEL-HOM1:xRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV:0VmlyUUN3ME2wMlA4OjV3IN88US=>MV3TRW5ITVJ?
HCC2998M1TGVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NW\4VHVKUUN3ME2wMlA4OzR5IN88US=>MYPTRW5ITVJ?
HuO9MoW5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH35elhKSzVyPUCuNFc2QDlizszNNX3pUZE5W0GQR1XS
CAL-39NGn3fVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVXJR|UxRTBwMEe3OlYh|ryPM3vjWHNCVkeHUh?=
M14NWTYfHN{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlrFTWM2OD1yLkC3PVE{KM7:TR?=M3XlfHNCVkeHUh?=
BFTC-909M4LHSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3;2SGlEPTB;MD6wO|k3QSEQvF2=NVexPJZ4W0GQR1XS
TE-11MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHTU[GVKSzVyPUCuNFc6QTZizszNMoHyV2FPT0WU
TGBC1TKBNWLJ[nhPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFTrcYNKSzVyPUCuNFgxPDNizszNNWTXeo1iW0GQR1XS
L-363NEjyeFVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mly5TWM2OD1yLkC4NlA3KM7:TR?=MX;TRW5ITVJ?
A431NYK1eo9jT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoPvTWM2OD1yLkC4NlEh|ryPNI\FOHlUSU6JRWK=
MKN45MofGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXzuW5BNUUN3ME2wMlA5OjF7IN88US=>M3flSnNCVkeHUh?=
HT-1080M13KPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmqwTWM2OD1yLkC4OFM6KM7:TR?=NV3vWpk3W0GQR1XS
OVCAR-8M{n6bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXjJR|UxRTBwMEi2NlIh|ryPMV;TRW5ITVJ?
LCLC-97TM1MkTrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3qzOWlEPTB;MD6wPFczQCEQvF2=NWn4ZmtPW0GQR1XS
M059JNEO2NnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIfRUHdKSzVyPUCuNFkxOjdizszNMl7QV2FPT0WU
SK-MEL-2M{WwXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4nv[GlEPTB;MD6wPVA3KM7:TR?=NVX5XGtOW0GQR1XS
TE-1NXzHT5pXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHvYTHpKSzVyPUCuNFkzODRizszNMV7TRW5ITVJ?
KYSE-180Ml;mS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn;yTWM2OD1yLkC5NlYzKM7:TR?=MlPQV2FPT0WU
D-247MGMlqxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFfzNZFKSzVyPUCuNFk1PTVizszNNUTicoxTW0GQR1XS
8-MG-BANEXC[41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUTabWxjUUN3ME2wMlA6PDd{IN88US=>Mk[4V2FPT0WU
NCI-H1792NWLZSnNoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWTkSZpGUUN3ME2wMlA6PjF6IN88US=>M3L2Z3NCVkeHUh?=
MCF7MoDIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF;vOFJKSzVyPUCuNFk3PzdizszNNX[2cmZSW0GQR1XS
NCI-H2122NH;JNnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmHFTWM2OD1yLkC5O|Q2KM7:TR?=MVfTRW5ITVJ?
EFO-27MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX3wW5U1UUN3ME2wMlA6QTl5IN88US=>NYKz[I9EW0GQR1XS
LB2241-RCCNEjsZo5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2DCSmlEPTB;MD6xNFA2PCEQvF2=NUTFW5N3W0GQR1XS
SN12CMUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmT4TWM2OD1yLkGwNVA4KM7:TR?=MoLVV2FPT0WU
A498NWGyfnVST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWTJR|UxRTBwMUCxPEDPxE1?M{fHU3NCVkeHUh?=
PANC-03-27M4XnT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{O4WmlEPTB;MD6xNFI5PiEQvF2=NFO5N|dUSU6JRWK=
NCI-H1581NFTKZ|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVnpV4hqUUN3ME2wMlExOjlizszNM1zmcnNCVkeHUh?=
U-87-MGMnLiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYDJR|UxRTBwMUCzNFch|ryPM{m2SXNCVkeHUh?=
G-401MoLoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmnoTWM2OD1yLkGwN|U{KM7:TR?=MlH2V2FPT0WU
SiHaMYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEHEUItKSzVyPUCuNVA1QDZizszNMmn4V2FPT0WU
U251MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVrMdlVPUUN3ME2wMlExPTJ3IN88US=>NVrQeZpyW0GQR1XS
MMAC-SFNIfqcHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2LVe2lEPTB;MD6xNFU{OSEQvF2=NFrmOXhUSU6JRWK=
BB65-RCCM1L1eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVW4bFZZUUN3ME2wMlExPTV2IN88US=>MoHtV2FPT0WU
NKM-1MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFzkfoxKSzVyPUCuNVA3PjZizszNMUnTRW5ITVJ?
HD-MY-ZMVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmP2TWM2OD1yLkGwPFc{KM7:TR?=MmfqV2FPT0WU
TGBC11TKBMV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlLpTWM2OD1yLkGwPVA{KM7:TR?=NUj4U2lZW0GQR1XS
COLO-679M1T3Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH3nR2VKSzVyPUCuNVEzOTFizszNMVHTRW5ITVJ?
TE-8NYT5OHF4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mm[2TWM2OD1yLkGxNlY1KM7:TR?=NEWweZRUSU6JRWK=
SK-MEL-28MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWTJR|UxRTBwMUGzNlEh|ryPNEPNVJNUSU6JRWK=
SH-4M4\5VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnHhTWM2OD1yLkGxN|U3KM7:TR?=MkThV2FPT0WU
KALS-1MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVL6VmhGUUN3ME2wMlEyOzl|IN88US=>MYTTRW5ITVJ?
RKOM3PHcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFj5eFBKSzVyPUCuNVE4PjRizszNNHXLfllUSU6JRWK=
OMC-1MlrCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1nOUmlEPTB;MD6xNVc6PyEQvF2=MYPTRW5ITVJ?
BT-549M13ZUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWDXR2hmUUN3ME2wMlEyPzl7IN88US=>MYfTRW5ITVJ?
NCI-H28NHnPUG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2rDTmlEPTB;MD6xNVgyPyEQvF2=MUnTRW5ITVJ?
RXF393NFe5cZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYPRT5BHUUN3ME2wMlEyQTh{IN88US=>M{\1[nNCVkeHUh?=
COLO-829NVXBXGVvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYjvb3J1UUN3ME2wMlEzODB3IN88US=>MWLTRW5ITVJ?
HMV-IINH7ad4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4m4ZmlEPTB;MD6xNlAzKM7:TR?=M3nEcXNCVkeHUh?=
SW1990NUi4PJFMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1Pv[2lEPTB;MD6xNlE2PyEQvF2=MnPEV2FPT0WU
NCI-H1437M{PVcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXrPWXRMUUN3ME2wMlEzOTV5IN88US=>MlXYV2FPT0WU
SNB75M1LNbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3;5eWlEPTB;MD6xNlE3QSEQvF2=NHXofGdUSU6JRWK=
EW-3MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYfJR|UxRTBwMUK2OlEh|ryPM{XEOHNCVkeHUh?=
SASM4HibWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYrJR|UxRTBwMUK2PUDPxE1?NXHESm03W0GQR1XS
NCI-H1666MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmDqTWM2OD1yLkGyO|c1KM7:TR?=NWTMeoNvW0GQR1XS
A375M33HWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3f5dGlEPTB;MD6xNlc4QCEQvF2=MoX1V2FPT0WU
CAMA-1M{HpTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NELvbVlKSzVyPUCuNVI6OjRizszNNWrtem5VW0GQR1XS
HuP-T4M1fUWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2nQZWlEPTB;MD6xNlk1OyEQvF2=MWfTRW5ITVJ?
NCI-H292M4j0N2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnOxTWM2OD1yLkGzNVEh|ryPMVnTRW5ITVJ?
PC-14MmDMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmrHTWM2OD1yLkGzNlEyKM7:TR?=MY\TRW5ITVJ?
BPH-1NIj0UFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlrYTWM2OD1yLkGzOFEh|ryPNWfKNYFjW0GQR1XS
GAKMX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVXJR|UxRTBwMUO1Olch|ryPMVvTRW5ITVJ?
VMRC-RCZNGrhS4FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGHUe|FKSzVyPUCuNVM4PjJizszNNYq2SnNPW0GQR1XS
SK-MEL-24MlLjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYLJR|UxRTBwMUO4O{DPxE1?Ml\WV2FPT0WU
LB831-BLCMX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NETRfm5KSzVyPUCuNVM5QDNizszNMorKV2FPT0WU
NCI-H2452MknsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NITvV3hKSzVyPUCuNVM6PTZizszNMXjTRW5ITVJ?
RT-112MlvSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3nMbmlEPTB;MD6xOFA{PSEQvF2=NF7CZnBUSU6JRWK=
GP5dNF\vZ|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEnFNnRKSzVyPUCuNVQyODRizszNMVjTRW5ITVJ?
LC-2-adNWTTd4hzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXTSNYozUUN3ME2wMlE1OTJzIN88US=>Mn21V2FPT0WU
MPP-89MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYTJR|UxRTBwMUSxNlUh|ryPM4[2XXNCVkeHUh?=
NUGC-3Mlm1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1PnWWlEPTB;MD6xOFQ4QCEQvF2=Mk\GV2FPT0WU
GI-1NF33cINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2X0bWlEPTB;MD6xOFU2QCEQvF2=NI\XdmRUSU6JRWK=
HCC1419MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmXDTWM2OD1yLkG0OVc3KM7:TR?=M2XmU3NCVkeHUh?=
SW1573MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVfJR|UxRTBwMUS3OVgh|ryPNHLRe|ZUSU6JRWK=
NCI-H2347NUjTXWJoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mo\OTWM2OD1yLkG0PFM6KM7:TR?=NVn5O4hpW0GQR1XS
MewoNUTxNldXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1;ac2lEPTB;MD6xOFg5QSEQvF2=M4H6bXNCVkeHUh?=
639-VNHvOcolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NI\GSpZKSzVyPUCuNVUxOTNizszNMkX3V2FPT0WU
AsPC-1M1PZ[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NULOU3E2UUN3ME2wMlE2OjJ3IN88US=>MmK0V2FPT0WU
NCI-H1648M3jD[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1z2NWlEPTB;MD6xOVI{OiEQvF2=NF;M[oNUSU6JRWK=
786-0NYryN3FNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWnJR|UxRTBwMUWzPFEh|ryPNF;kRYRUSU6JRWK=
ETK-1MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NI\a[4FKSzVyPUCuNVU6KM7:TR?=M3XJWnNCVkeHUh?=
BxPC-3M2ixOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXLJR|UxRTBwMUW5OlYh|ryPMXzTRW5ITVJ?
CAL-62NF;aZoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGjHZpZKSzVyPUCuNVYyPjlizszNMmK5V2FPT0WU
HCC1937M1jlcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{T3fWlEPTB;MD6xOlI4PSEQvF2=MW\TRW5ITVJ?
NCI-H1299M1O0Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3nRdWlEPTB;MD6xOlI5PSEQvF2=MkfvV2FPT0WU
SW1088NXfhWIZ4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmL6TWM2OD1yLkG2OFE{KM7:TR?=MkC2V2FPT0WU
FTC-133MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVHJR|UxRTBwMU[1OEDPxE1?NG\3RlhUSU6JRWK=
OC-314MmXNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF3QN4RKSzVyPUCuNVY3QSEQvF2=MV7TRW5ITVJ?
SCC-9NXPOSG81T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV3UZ4tUUUN3ME2wMlE3PzF4IN88US=>NUnLc|d1W0GQR1XS
HT-1376NV\EfpNsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH7LXFVKSzVyPUCuNVY6OzZizszNM2DGVnNCVkeHUh?=
U-2-OSNEn5fI5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHLhZ5JKSzVyPUCuNVcyPzNizszNNWnReW9[W0GQR1XS
COLO-824MlPUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4LBXWlEPTB;MD6xO|I6PCEQvF2=NYDjWpdkW0GQR1XS
BB30-HNCM2TSTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWDJR|UxRTBwMUezN{DPxE1?NVnrOZhWW0GQR1XS
NCI-H2087M17EXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlPLTWM2OD1yLkG3N|Y5KM7:TR?=MlXkV2FPT0WU
NCI-H2170NV7vRplzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3jmWGlEPTB;MD6xO|U{PiEQvF2=NF;QfFJUSU6JRWK=
SK-OV-3M1TCd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX\MU5RNUUN3ME2wMlE4PTdzIN88US=>NGHTRZdUSU6JRWK=
MZ7-melNETCUVZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mk[xTWM2OD1yLkG3OlQ6KM7:TR?=NV;uVVJQW0GQR1XS
NCI-H650NF[zUmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXq2UVdtUUN3ME2wMlE4Pjh{IN88US=>NXrXNZVLW0GQR1XS
KOSC-2NUHvfFVuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2r1bmlEPTB;MD6xO|c{PCEQvF2=MYrTRW5ITVJ?
SCC-4NXTvT212T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1;FNWlEPTB;MD6xO|c4PyEQvF2=Mnr5V2FPT0WU
MDA-MB-157MkPkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2HoSmlEPTB;MD6xPFA5OiEQvF2=NWDLfpUzW0GQR1XS
KYSE-520NHTIfXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml3mTWM2OD1yLkG4NkDPxE1?M362cnNCVkeHUh?=
LK-2NVLGbmdvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUWzT4h2UUN3ME2wMlE5OzB|IN88US=>Mk\qV2FPT0WU
KNS-81-FDNF3zS|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NInUNJZKSzVyPUCuNVg{QTRizszNMUjTRW5ITVJ?
IGROV-1NVzKWog2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1LYO2lEPTB;MD6xPFQ1OyEQvF2=Moi4V2FPT0WU
DELNF3tc3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVLJR|UxRTBwMUi0OUDPxE1?NVXUWJRpW0GQR1XS
NCI-H1395M{myfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFTNeXJKSzVyPUCuNVg3QDJizszNMlPwV2FPT0WU
JEG-3NYDNclUxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFLoNYxKSzVyPUCuNVg4ODVizszNMXzTRW5ITVJ?
BCPAPNELrfnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXP2SFhHUUN3ME2wMlE5QDd{IN88US=>M37TV3NCVkeHUh?=
CAL-27Moe0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoWwTWM2OD1yLkG5NFIzKM7:TR?=M4Dn[nNCVkeHUh?=
RDMUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2H3XWlEPTB;MD6xPVEyOyEQvF2=NW\5bJFRW0GQR1XS
RVH-421NXfpe|F7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnH6TWM2OD1yLkG5NVE3KM7:TR?=NXPa[W45W0GQR1XS
Capan-2Mn:yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXLjO49VUUN3ME2wMlE6OjV4IN88US=>NVu5NVd4W0GQR1XS
COLO-680NMortS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3PxZ2lEPTB;MD6xPVM3PCEQvF2=NIPLWpVUSU6JRWK=
NCI-H1650NWLueWQ5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{PQS2lEPTB;MD6yNFA2PyEQvF2=NFzxWIlUSU6JRWK=
SBC-5MkfuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVmyPW1JUUN3ME2wMlIxOTF6IN88US=>NIH0[2NUSU6JRWK=
U031NITOPXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVzaNZROUUN3ME2wMlIxPTR5IN88US=>NEWwTFJUSU6JRWK=
S-117NFHrNoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTBwMkC1OlQh|ryPM4TMfHNCVkeHUh?=
DoTc2-4510MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MY\JR|UxRTBwMkC3Olkh|ryPNEXFPXVUSU6JRWK=
AM-38MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWDJR|UxRTBwMkC4OFgh|ryPMVTTRW5ITVJ?
A172M{TCUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1T4NGlEPTB;MD6yNVAzOiEQvF2=NVHaWXB6W0GQR1XS
HPAF-IIMVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlLLTWM2OD1yLkKxNlY1KM7:TR?=NFPnV2pUSU6JRWK=
769-PMXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlzqTWM2OD1yLkKxNlgh|ryPNFnLPHVUSU6JRWK=
MFE-280NVzucnJRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIn5[W9KSzVyPUCuNlEzQThizszNNFvpfXJUSU6JRWK=
TE-9NYrF[G5sT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnPuTWM2OD1yLkKxO|g3KM7:TR?=MYfTRW5ITVJ?
C2BBe1NXSxWXU5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml;JTWM2OD1yLkKyNVkh|ryPNEm0NGNUSU6JRWK=
EoL-1-cellMW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXTJR|UxRTBwMkKyNFMh|ryPMlmxV2FPT0WU
G-361M3Oxb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1vPN2lEPTB;MD6yNlY5OiEQvF2=MVXTRW5ITVJ?
KYSE-270NIDhepVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MU\JR|UxRTBwMkOwPFQh|ryPM4LxRXNCVkeHUh?=
TK10MmXaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGrwTJRKSzVyPUCuNlMyOTdizszNNV\Yco0yW0GQR1XS
ML-2M4\5b2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVrJR|UxRTBwMkOxNVkh|ryPM{CwNHNCVkeHUh?=
MHH-ES-1M4LKV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn;XTWM2OD1yLkKzOlgyKM7:TR?=Mlq2V2FPT0WU
BHYNInJU3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX;JR|UxRTBwMkO2PVEh|ryPM{iyO3NCVkeHUh?=
LS-513M3XmZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVHJR|UxRTBwMkO5OlEh|ryPM2Szc3NCVkeHUh?=
COLO-678NGj4WHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH:xcJFKSzVyPUCuNlQxPDRizszNMmr1V2FPT0WU
NCI-H747NEDLeZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1nvPWlEPTB;MD6yOFE3QSEQvF2=NIPJVVhUSU6JRWK=
K5M{LlcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUnWdYRZUUN3ME2wMlI1OzhizszNNUG2d5MzW0GQR1XS
OS-RC-2MlXnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVrJR|UxRTBwMkS1NFkh|ryPMVLTRW5ITVJ?
KINGS-1MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NELFZ|hKSzVyPUCuNlQ2OjlizszNNH\xWodUSU6JRWK=
SCC-25NUG0W4IzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnnSTWM2OD1yLkK0OVY{KM7:TR?=NW\3d204W0GQR1XS
CAPAN-1MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWrhW5I2UUN3ME2wMlI1Pzh|IN88US=>MYrTRW5ITVJ?
ESS-1MkGzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmLDTWM2OD1yLkK0PFA2KM7:TR?=NFroU3VUSU6JRWK=
TE-6M3TWcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1\PUmlEPTB;MD6yOVc2KM7:TR?=NX7odIpVW0GQR1XS
LB2518-MELNHe0bnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnzKTWM2OD1yLkK1O|c4KM7:TR?=MkPHV2FPT0WU
COLO-800NWHpOmZET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWjGUZBSUUN3ME2wMlI2QDF{IN88US=>M3LtfHNCVkeHUh?=
LU-134-AMWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1jMPGlEPTB;MD6yOlE{PiEQvF2=NH\qR3BUSU6JRWK=
NCI-H1155MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYfJR|UxRTBwMk[xOlIh|ryPNGjtbplUSU6JRWK=
MFM-223MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3H2VmlEPTB;MD6yOlM3OyEQvF2=NVXzW3FGW0GQR1XS
HTC-C3MkniS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmDnTWM2OD1yLkK2OVA3KM7:TR?=NVzPNoZtW0GQR1XS
HCT-116MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{nZZmlEPTB;MD6yOlU6QSEQvF2=NWHPPWk6W0GQR1XS
Ca-SkiM2\WTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mor3TWM2OD1yLkK2Olc5KM7:TR?=MlHJV2FPT0WU
SBC-1NXTobXJwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NU\XdVFMUUN3ME2wMlI3PzR{IN88US=>NF\a[opUSU6JRWK=
NB69NF;DPVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkPVTWM2OD1yLkK3NFg4KM7:TR?=MmPBV2FPT0WU
J82MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX7JR|UxRTBwMkeyOlUh|ryPM3\qPHNCVkeHUh?=
U-118-MGM3S2cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUPJR|UxRTBwMke1O|kh|ryPM1W1bXNCVkeHUh?=
NCI-H1355MlnGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVXJR|UxRTBwMkiwO|Qh|ryPNUXBXmlpW0GQR1XS
NCI-H1048M1XJemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MljhTWM2OD1yLkK4PVU3KM7:TR?=MYLTRW5ITVJ?
SW954NILaRnhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NX\IdYNtUUN3ME2wMlI6OjJ5IN88US=>M3W2PHNCVkeHUh?=
NMC-G1M4rXcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHuyOFNKSzVyPUCuNlkzPzdizszNNUfwOVBKW0GQR1XS
SW1710MmfvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFPZZ5pKSzVyPUCuNlk1QTRizszNM{Pa[HNCVkeHUh?=
KY821MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1HLVmlEPTB;MD6yPVg4OiEQvF2=NXPsSHFIW0GQR1XS
HCC38M1zt[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoXCTWM2OD1yLkOwNFc5KM7:TR?=M{nIeXNCVkeHUh?=
NCI-SNU-5NGPkfXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml;WTWM2OD1yLkOwOVQh|ryPMn3UV2FPT0WU
ES8NFvBTFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2DTXmlEPTB;MD6zNFc5PCEQvF2=MYPTRW5ITVJ?
COLO-792NIHuZXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH6xe25KSzVyPUCuN|EzPTFizszNMXLTRW5ITVJ?
BFTC-905NHO1bIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHzERlRKSzVyPUCuN|E2OjFizszNMX7TRW5ITVJ?
ChaGo-K-1MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnPkTWM2OD1yLkOxO|E2KM7:TR?=Mnz5V2FPT0WU
DaoyMmfpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUnJR|UxRTBwM{G3NlMh|ryPM{XESXNCVkeHUh?=
SJSA-1MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVrJR|UxRTBwM{G4OFch|ryPMUPTRW5ITVJ?
KNS-62NYj3UHB5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mk\JTWM2OD1yLkOyNFg5KM7:TR?=NIjHUYhUSU6JRWK=
CAKI-1NV\M[FJIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH;sc3lKSzVyPUCuN|IyOTFizszNM1rUUXNCVkeHUh?=
UACC-62NIryOnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NULwVoViUUN3ME2wMlMzOjJ5IN88US=>MUfTRW5ITVJ?
HuCCT1MmDOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYnJR|UxRTBwM{KyPFMh|ryPNXPFVnB2W0GQR1XS
CTB-1NFXYTpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmrRTWM2OD1yLkOyO|U{KM7:TR?=NH7m[5hUSU6JRWK=
NTERA-S-cl-D1NVLZV5I3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoPzTWM2OD1yLkOyPFM3KM7:TR?=MYXTRW5ITVJ?
T-24MoTZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2rYRmlEPTB;MD6zN|E2QSEQvF2=MnLWV2FPT0WU
KYSE-70M37TdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlrVTWM2OD1yLkOzNlg{KM7:TR?=NFPZ[m5USU6JRWK=
SW626MkLHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV;JR|UxRTBwM{O1N|Ih|ryPNG\TSI1USU6JRWK=
LB996-RCCNH;vdIZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVTQem81UUN3ME2wMlM{PjF7IN88US=>M4Pnb3NCVkeHUh?=
DMS-273MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2XPdmlEPTB;MD6zN|kyPiEQvF2=NHTqOHNUSU6JRWK=
SW1783M4[xbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MY\JR|UxRTBwM{O5PVch|ryPMXHTRW5ITVJ?
KU812M1LlV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWTHfWl4UUN3ME2wMlM1ODN6IN88US=>NGLkPJFUSU6JRWK=
HSC-2MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn7ITWM2OD1yLkO0NFU{KM7:TR?=NIXWeoZUSU6JRWK=
A3-KAWMlXwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn7kTWM2OD1yLkO0NVYzKM7:TR?=NFjZcoVUSU6JRWK=
COLO-684MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIDCV|FKSzVyPUCuN|Q2ODFizszNNVjyeXltW0GQR1XS
NCI-H2405MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NE\FSGtKSzVyPUCuN|Q3OzFizszNMlz2V2FPT0WU
NCI-H2228M4HueGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUn0[3V7UUN3ME2wMlM2OzV5IN88US=>Ml[wV2FPT0WU
NB13MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVfvcWRnUUN3ME2wMlM3QDJ7IN88US=>MV\TRW5ITVJ?
no-11MmDXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF70NZpKSzVyPUCuN|Y6PSEQvF2=MmnHV2FPT0WU
DK-MGNE\ucohIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlfuTWM2OD1yLkO3NVg5KM7:TR?=M4TFSnNCVkeHUh?=
NBsusSRM1G3Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mne1TWM2OD1yLkO3Nlg2KM7:TR?=NGToN|hUSU6JRWK=
KP-N-YSNE\qU|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXywU|RMUUN3ME2wMlM4PDZ|IN88US=>NGXlU49USU6JRWK=
CFPAC-1NH[wc2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NW\SfVRZUUN3ME2wMlM4PTF6IN88US=>MXzTRW5ITVJ?
KARPAS-45NGrUUZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXLHTIw1UUN3ME2wMlM4QDZ{IN88US=>MmraV2FPT0WU
NCI-H1793NILlNI1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGPLRpBKSzVyPUCuN|g2OSEQvF2=NIPhR3RUSU6JRWK=
HCE-TNYTCUG1DT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NE\2UXBKSzVyPUCuN|g3ODNizszNMYjTRW5ITVJ?
NCI-H520M13zdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIW0UWtKSzVyPUCuN|g4ODNizszNNFLpVJpUSU6JRWK=
HCC2157MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml;KTWM2OD1yLkO4O|gyKM7:TR?=NELkXoZUSU6JRWK=
EW-18MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVnJR|UxRTBwM{i5OFEh|ryPMX;TRW5ITVJ?
RO82-W-1NFPoPFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4fDXGlEPTB;MD6zPVY6QSEQvF2=MVLTRW5ITVJ?
HuP-T3NHLUbWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHXJZZhKSzVyPUCuOFAyPDNizszNMmXmV2FPT0WU
PANC-10-05MoLjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmrBTWM2OD1yLkSxNVch|ryPNH3Ic4pUSU6JRWK=
NCI-H1703NUfkS|FzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml;lTWM2OD1yLkSxOFQ3KM7:TR?=MVLTRW5ITVJ?
TE-10M{O5fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXLwTlZFUUN3ME2wMlQyPDR5IN88US=>Ml34V2FPT0WU
HOSM4PNUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYPJR|UxRTBwNEG2PFIh|ryPMYfTRW5ITVJ?
LN-405MmqxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEDIS21KSzVyPUCuOFE3QDdizszNM{izXXNCVkeHUh?=
A427NFzKTFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGnLdW5KSzVyPUCuOFE6QDFizszNMlv3V2FPT0WU
CAL-12TMVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmLqTWM2OD1yLkSyO|gh|ryPM{LJfHNCVkeHUh?=
SW756NGPOUmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2\uOmlEPTB;MD60OFE5OyEQvF2=M1T0bnNCVkeHUh?=
YAPCMlvIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NU\FWVVYUUN3ME2wMlQ2ODhizszNNHT4eHhUSU6JRWK=
GOTONF34TndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnW1TWM2OD1yLkS1NVYh|ryPMYrTRW5ITVJ?
C3AMYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYLJR|UxRTBwNEW0N|ch|ryPNWjCbVRZW0GQR1XS
UM-UC-3MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF31WoVKSzVyPUCuOFU1PyEQvF2=MnO4V2FPT0WU
NCI-H1573NU\ITo8{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4fSPWlEPTB;MD60OVU3QSEQvF2=NWjFPVRmW0GQR1XS
LS-411NMmPwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEj2eVBKSzVyPUCuOFY2OjdizszNNEi1WFFUSU6JRWK=
COR-L23M{XxcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV3JR|UxRTBwNE[3OlQh|ryPNEHIfIpUSU6JRWK=
HCE-4MlL3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGe3S2tKSzVyPUCuOFc1PDZizszNNUL6c4F5W0GQR1XS
NCI-H2291NHjrXppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnLQTWM2OD1yLkS3PFk3KM7:TR?=MWrTRW5ITVJ?
A101DMmD1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGnZRZVKSzVyPUCuOFgxPTNizszNNI\ZN4xUSU6JRWK=
HT-3NHrPVnVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVzJR|UxRTBwNEiyNVch|ryPM1TQeXNCVkeHUh?=
HOP-62MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn;ITWM2OD1yLkS5PFY2KM7:TR?=NWDQWm5TW0GQR1XS
PC-3MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1myVWlEPTB;MD61NVUxPyEQvF2=MWPTRW5ITVJ?
CTV-1Mn7KS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlnRTWM2OD1yLkWyOlY6KM7:TR?=MXjTRW5ITVJ?
PANC-08-13Ml34S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVvJR|UxRTBwNUOxO|ch|ryPMlPUV2FPT0WU
CAL-120MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M17FO2lEPTB;MD61N|M6QSEQvF2=NE[3d5JUSU6JRWK=
UMC-11NES3U4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4HJPWlEPTB;MD61OVI{PCEQvF2=MXjTRW5ITVJ?
MSTO-211HM2jIeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX7JR|UxRTBwNUW3OlIh|ryPMmjZV2FPT0WU
NCI-H2126MlnxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXTJR|UxRTBwNU[4NVUh|ryPM4fHb3NCVkeHUh?=
SNU-C2BM3PoS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV3JR|UxRTBwNUe5O|ch|ryPMlS1V2FPT0WU
DBTRG-05MGMUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmT1TWM2OD1yLkW4NFU{KM7:TR?=MlTOV2FPT0WU
MKN1NXHSUZNZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml3KTWM2OD1yLkW4O|g{KM7:TR?=NYrSUow{W0GQR1XS
ES3NX\2NZRnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXXJR|UxRTBwNUmxNlQh|ryPNXPaeWtbW0GQR1XS
OVCAR-3MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2HFSmlEPTB;MD61PVM1OSEQvF2=MoDhV2FPT0WU
ACHNMUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVm4bIo4UUN3ME2wMlYxPTZ7IN88US=>NY[weGZ2W0GQR1XS
SW872M3O0Tmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGT3NphKSzVyPUCuOlA4PjNizszNM3XBZXNCVkeHUh?=
CP66-MELMYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWKzRZduUUN3ME2wMlYxQTZ7IN88US=>Mn;pV2FPT0WU
NCI-H661M1rwTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NG\zcZZKSzVyPUCuOlEyODRizszNMUHTRW5ITVJ?
UACC-893M2rw[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEPpOlFKSzVyPUCuOlM3QDFizszNNIP4XWZUSU6JRWK=
JVM-3NFjvUm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVPJR|UxRTBwNkO4NFQh|ryPNYnmPGl2W0GQR1XS
SF268NGnIeVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXjPc25mUUN3ME2wMlY1OzR7IN88US=>MnP2V2FPT0WU
OCI-AML2NIHFb|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXHJR|UxRTBwNkWzPVch|ryPNHq3OJBUSU6JRWK=
RPMI-8226NUfueFNiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{nEcmlEPTB;MD62OlMzOyEQvF2=MnHtV2FPT0WU
MKN28NVfJZZhVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXHJR|UxRTBwNk[2NlQh|ryPMX;TRW5ITVJ?
MDA-MB-453NV7OemVZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGjsbplKSzVyPUCuOlcyQCEQvF2=NFXRTHVUSU6JRWK=
BV-173MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHnXTHhKSzVyPUCuOlg3PzlizszNNXHEO2t2W0GQR1XS
NCI-H358NE\6TnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXjhc3VFUUN3ME2wMlY5PzJ4IN88US=>NGq4XWdUSU6JRWK=
NCI-H1651NGTT[opIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlrnTWM2OD1yLkeg{txOM1XBd3NCVkeHUh?=
MDA-MB-415NE\UR41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGjTelhKSzVyPUCuO|A5OjlizszNNIjTV2dUSU6JRWK=
8305CNYG2c49zT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NI\hd45KSzVyPUCuO|I1QThizszNMkCyV2FPT0WU
EFM-19MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnTDTWM2OD1yLkezOlcyKM7:TR?=MXjTRW5ITVJ?
RERF-LC-MSNF;N[4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MU\JR|UxRTBwN{S2NVMh|ryPMX\TRW5ITVJ?
A388MoOzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3T6R2lEPTB;MD63OlQ3PyEQvF2=M1TPSXNCVkeHUh?=
GI-ME-NMk\HS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUjJR|UxRTBwN{eyN|Uh|ryPNXzXeoJLW0GQR1XS
IGR-1NY[1e4JvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1;4XWlEPTB;MD63PVA1OyEQvF2=NHzxfW1USU6JRWK=
LNCaP-Clone-FGCMmn6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYjJR|UxRTBwOECwNFQh|ryPNUH2eFlzW0GQR1XS
SK-MEL-3MoDOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmLITWM2OD1yLkixOVA5KM7:TR?=MlqwV2FPT0WU
UACC-257NXfYXVJ{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXm5NXZ{UUN3ME2wMlgzOjNzIN88US=>NFi0PJlUSU6JRWK=
OE33M4L4d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV;JR|UxRTBwOEWxNFEh|ryPMnrLV2FPT0WU
QIMR-WILMVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIDY[mVKSzVyPUCuPFUyPDFizszNMVfTRW5ITVJ?
NCI-H2009Ml;oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmPzTWM2OD1yLki1N|EyKM7:TR?=NHX6dWlUSU6JRWK=
NCI-H522M4fTVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3nOdmlEPTB;MD64O|c5OyEQvF2=Ml3CV2FPT0WU
Saos-2NGTPN3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUjJR|UxRTBwOEe4O|Eh|ryPNHnK[VdUSU6JRWK=
NB17NXXhd5B1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUHFVZZ7UUN3ME2wMlg5ODJ3IN88US=>NVvtWldpW0GQR1XS
D-392MGNYTodnVET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXjLNnllUUN3ME2wMlg6OzV4IN88US=>NWKzbpF4W0GQR1XS
SHP-77M1nGUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWXJR|UxRTBwOUC0PFUh|ryPMlOwV2FPT0WU
SK-MEL-30NF3PUFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWfKVnp1UUN3ME2wMlkyOTh3IN88US=>NYPBcYtzW0GQR1XS
GCIYM2PDWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHvpSohKSzVyPUCuPVE5PDNizszNMVfTRW5ITVJ?
HCC70NYTr[mExT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVPJR|UxRTBwOUKwOVkh|ryPM{Hm[nNCVkeHUh?=
LU-65NFn4ZmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYrJR|UxRTBwOUK1PVEh|ryPM4LTe3NCVkeHUh?=
NCI-H1563M33RZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M13OfmlEPTB;MD65OFg3PSEQvF2=MXfTRW5ITVJ?
KURAMOCHINX2yVXUxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWC5NmRtUUN3ME2wMlk2OTl{IN88US=>NXj0NVNTW0GQR1XS
PA-1M33Wemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEnseoJKSzVyPUCuPVU1OjRizszNMWLTRW5ITVJ?
NOS-1MoS0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkDmTWM2OD1yLkm3OFg6KM7:TR?=MV3TRW5ITVJ?
NCI-H69MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHP3ZYdKSzVyPUCuPVc3OzRizszNNYq1TlcxW0GQR1XS
KYSE-450MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF7ocIpKSzVyPUCuPVg3OjZizszNNWXMdFBCW0GQR1XS
8505CNW\Pe|dxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1OxNmlEPTB;MD65PVk5OiEQvF2=M1;NUnNCVkeHUh?=
TGBC24TKBMVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NU\Xe4RMUUN3ME2xMlAxODh2IN88US=>NGTHR|ZUSU6JRWK=
PFSK-1MojnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWXTO45OUUN3ME2xMlAyPDJ6IN88US=>NWXGcVhkW0GQR1XS
EKVXNF3wXoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVKxbGdZUUN3ME2xMlA{OTJzIN88US=>M13rc3NCVkeHUh?=
RCM-1NEXDeGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlTFTWM2OD1zLkC1OVA4KM7:TR?=MlzKV2FPT0WU
SW900M{fFNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmTWTWM2OD1zLkC3PFMh|ryPM17jO3NCVkeHUh?=
D-542MGM2O3cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUHJR|UxRTFwMEe4OVUh|ryPMojiV2FPT0WU
SK-PN-DWMl;JS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MULJR|UxRTFwMUCwOVYh|ryPMlvUV2FPT0WU
NCI-H727M361Xmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYXJR|UxRTFwMUCxOVQh|ryPNEDhWnNUSU6JRWK=
SW837NWnlUZp3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYHJR|UxRTFwMUC5OVQh|ryPMYLTRW5ITVJ?
BT-20MmfuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIXsTm1KSzVyPUGuNVEzODRizszNMXXTRW5ITVJ?
RH-18M3\OVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUXJR|UxRTFwMUOxNFMh|ryPMn3WV2FPT0WU
TE-12NWXITYx1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF;LflFKSzVyPUGuNVM{OzNizszNM3XERnNCVkeHUh?=
NB10MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEXPbm1KSzVyPUGuNVM{PDRizszNNXXVRXhYW0GQR1XS
AU565NECyPIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmHSTWM2OD1zLkG1PVc{KM7:TR?=M2X3W3NCVkeHUh?=
OAW-42NF7uSXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2D0SWlEPTB;MT6xPFMxPiEQvF2=NF:zfGpUSU6JRWK=
DJM-1MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MU\JR|UxRTFwMUm4PFEh|ryPNEDGU4ZUSU6JRWK=
HHM2fnNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWrJR|UxRTFwMkO4N|Eh|ryPNUXSbHJSW0GQR1XS
LAMA-84M{O5dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF\6bZRKSzVyPUGuNlc{QTRizszNNUPVSHdsW0GQR1XS
KNS-42Mn3QS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGjXNpdKSzVyPUGuN|AzQTZizszNMmrNV2FPT0WU
NCI-H2052M2TnR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGrmeldKSzVyPUGuN|A2ODdizszNNVvHZYpOW0GQR1XS
MLMAMYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXzNZXpxUUN3ME2xMlMzPDB5IN88US=>MUjTRW5ITVJ?
NB12NGDXbFRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3HjV2lEPTB;MT6zOVY{PiEQvF2=M2rKSXNCVkeHUh?=
NCI-H1838NHuxT4RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXPmZlJoUUN3ME2xMlM3OzB4IN88US=>M2fi[3NCVkeHUh?=
NCI-H526M4jUVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXrJR|UxRTFwM{e4OVMh|ryPNHjNeoRUSU6JRWK=
LS-123MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV;JR|UxRTFwM{mwPVQh|ryPNUTQb2NmW0GQR1XS
HDLM-2NUK1XXFYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFTpN2ZKSzVyPUGuN|kzPzFizszNM{XDSHNCVkeHUh?=
MC-IXCM4jpUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{\PNGlEPTB;MT60NlM4OSEQvF2=MXPTRW5ITVJ?
HCT-15M1TWVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{\JTmlEPTB;MT60N|A3QCEQvF2=MYjTRW5ITVJ?
NCI-H596MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmPCTWM2OD1zLkS1NFYyKM7:TR?=MlXpV2FPT0WU
ZR-75-30NX3WNFIzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIG1dINKSzVyPUGuOFcxQDJizszNNWnWZpl6W0GQR1XS
A704NF\tc2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXrHUlhlUUN3ME2xMlY3PTZ|IN88US=>MVvTRW5ITVJ?
OVCAR-4MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mk\KTWM2OD1zLk[5OlA4KM7:TR?=NFTk[mpUSU6JRWK=
SW1417NHH5d2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTFwN{K4OFkh|ryPMXTTRW5ITVJ?
CAS-1NX\nVI15T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1rIO2lEPTB;MT63N|k{PiEQvF2=MkTyV2FPT0WU
IST-SL1M1TaTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MojCTWM2OD1zLke5O|U6KM7:TR?=MoftV2FPT0WU
A253MnLxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXW1VXk6UUN3ME2xMlgzOjN7IN88US=>NIK3RWVUSU6JRWK=
EW-16MkmzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVjJR|UxRTFwOEK4O|Uh|ryPNFLNZnlUSU6JRWK=
SK-NEP-1MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnLXTWM2OD1zLki2PVg5KM7:TR?=NWDGb5d[W0GQR1XS
NCI-H226NYHlWoxoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXvJR|UxRTFwOEmzOVkh|ryPNFPPToFUSU6JRWK=
HOP-92NXfkdYw2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV3JR|UxRTFwOU[wPVkh|ryPMnywV2FPT0WU
NCI-H441NV3sfXkxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV3mPXJpUUN3ME2yMlAzOzN5IN88US=>NH\Pc25USU6JRWK=
LU-139MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mmm2TWM2OD1{LkCzNVE1KM7:TR?=Mnn0V2FPT0WU
SJRH30M4rXXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4j0SmlEPTB;Mj6wOFI2OyEQvF2=M{TacHNCVkeHUh?=
MG-63MlfrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmnDTWM2OD1{LkG0NVEyKM7:TR?=MV\TRW5ITVJ?
NH-12NGGzUJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXHvVnhvUUN3ME2yMlE2ODB4IN88US=>NUmwVYxqW0GQR1XS
NB7NEHFN5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYD3S3dSUUN3ME2yMlE6Pjd|IN88US=>M4DmdHNCVkeHUh?=
LB771-HNCM2PzW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2[xSmlEPTB;Mj6yNFU6PSEQvF2=NV[1UZBYW0GQR1XS
HCC1569MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXXpU2o1UUN3ME2yMlI1PTh|IN88US=>MWXTRW5ITVJ?
D-283MEDNGrsT|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NU[wNnNUUUN3ME2yMlI1Pzh{IN88US=>MXPTRW5ITVJ?
J-RT3-T3-5NIPxeVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXfoUINZUUN3ME2yMlI2OzVzIN88US=>NH36[IdUSU6JRWK=
ATN-1MkPRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX3JR|UxRTJwM{OwPFIh|ryPM3nxOHNCVkeHUh?=
HCC1954MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mor0TWM2OD1{LkO0OFA5KM7:TR?=NXLXbWtbW0GQR1XS
SCC-15NImzPGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnPmTWM2OD1{LkO5N|EzKM7:TR?=NV\4b4lzW0GQR1XS
COLO-668NYC3NoNzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF2wZ4tKSzVyPUKuOFMzKM7:TR?=M{jsRnNCVkeHUh?=
LB373-MEL-DMXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXTzcnk6UUN3ME2yMlU1Pjd5IN88US=>Ml7uV2FPT0WU
no-10Mmr1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NY\ZR|BlUUN3ME2yMlU1QTR5IN88US=>MYrTRW5ITVJ?
HT-1197M3;Y[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIqzcXFKSzVyPUKuOlMyQDhizszNM3vHc3NCVkeHUh?=
DU-145NF\GT2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUjVVnZsUUN3ME2yMlc6OTZ{IN88US=>NEKzO3dUSU6JRWK=
SK-N-ASMUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUTJR|UxRTJwOES2PVIh|ryPMXTTRW5ITVJ?
MOLT-4MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnSxTWM2OD1{Lki1N|IzKM7:TR?=MlHYV2FPT0WU
EW-22M{LwVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MonJTWM2OD1{LkmyPFQyKM7:TR?=M2\kdnNCVkeHUh?=
DBMYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXzFfmNDUUN3ME2yMlk4PzV7IN88US=>NG\6ZYlUSU6JRWK=
HL-60NWqyO4tPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2\BcWlEPTB;Mz6wOFM4PiEQvF2=Mn;DV2FPT0WU
SK-N-DZMUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MY\JR|UxRTNwMEWwO|Uh|ryPMUDTRW5ITVJ?
NYMnTRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVXJR|UxRTNwMEi1OFIh|ryPNWDKfZNkW0GQR1XS
T47DNHvEenBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn\GTWM2OD1|LkGwOVU5KM7:TR?=NVj1ZWduW0GQR1XS
NCI-H2029NGP5OVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NU\3S4J4UUN3ME2zMlIzPDd5IN88US=>NEfLeXpUSU6JRWK=
KARPAS-299M3TyXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFf5RZNKSzVyPUOuNlYxOjdizszNM3nPTHNCVkeHUh?=
KM-H2NWD4XmdwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIfJ[JdKSzVyPUOuN|A3QCEQvF2=MWPTRW5ITVJ?
CHP-134Ml6wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX3JR|UxRTNwNEezPUDPxE1?MkfmV2FPT0WU
22RV1MnHkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{n0XWlEPTB;Mz60PVE3QCEQvF2=MYXTRW5ITVJ?
NB5M2mwWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVLJR|UxRTNwNUC2PFkh|ryPM2\YXXNCVkeHUh?=
CW-2NWHxNnJ[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYXJR|UxRTNwNUWzNVQh|ryPMVrTRW5ITVJ?
EFO-21MmLSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX\JR|UxRTNwNU[5OEDPxE1?M4PQVnNCVkeHUh?=
HuH-7NV\6eG5sT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1ztbGlEPTB;Mz61PFQyPCEQvF2=MUDTRW5ITVJ?
ALL-PONWTHT3hiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmDtTWM2OD1|Lk[yN|M2KM7:TR?=MVXTRW5ITVJ?
EM-2MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn[xTWM2OD1|Lk[5NFEyKM7:TR?=MoPuV2FPT0WU
KLEMoHXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4fROGlEPTB;Mz63N|AzQSEQvF2=NHztV|RUSU6JRWK=
NEC8MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4TNeGlEPTB;Mz65NVgxQCEQvF2=MmD1V2FPT0WU
KP-N-YNMWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkjITWM2OD1|LkmzOFc3KM7:TR?=NXfFdmFmW0GQR1XS
SK-MEL-1MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnXwTWM2OD12LkCzOVE5KM7:TR?=NVv3OnZxW0GQR1XS
CAL-54NWDHbWdPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1;xdWlEPTB;ND6wOVkyKM7:TR?=MW\TRW5ITVJ?
MS-1MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2mwS2lEPTB;ND6xOlE2PSEQvF2=M2jXc3NCVkeHUh?=
NCI-H209MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml\0TWM2OD12LkK5PVk6KM7:TR?=MXTTRW5ITVJ?
NOMO-1NXjzfW42T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmSyTWM2OD12LkOyNVMyKM7:TR?=M2TUO3NCVkeHUh?=
RPMI-2650M37sT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4H1VmlEPTB;ND6zOlMzPyEQvF2=M2TlN3NCVkeHUh?=
NCI-H810NIn0O5BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2jnTmlEPTB;ND6zPVc{PiEQvF2=NIXCfnhUSU6JRWK=
Ca9-22NHvWRWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NX7vfpY5UUN3ME20MlQ2PjlzIN88US=>NXGySHZHW0GQR1XS
ES4NH\IbYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVjJR|UxRTRwNEewPVUh|ryPM{jBSXNCVkeHUh?=
ES6NVn0OZRJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVjhUmZ{UUN3ME20MlQ6PjV5IN88US=>MnT4V2FPT0WU
DMS-114NHrhfYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkfETWM2OD12LkW0OlkyKM7:TR?=MoTSV2FPT0WU
ONS-76NInMRYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MY\JR|UxRTRwNUe5OUDPxE1?MXzTRW5ITVJ?
K-562MlP4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3LaeWlEPTB;ND63N|gyPCEQvF2=MX\TRW5ITVJ?
MHH-NB-11M2j1XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlPNTWM2OD12Lke1OFYyKM7:TR?=Mn7xV2FPT0WU
Calu-3NYXWd212T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUPJOXN[UUN3ME20Mlc5PTR6IN88US=>M1vzcHNCVkeHUh?=
HT55M4fabWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWX1dpA5UUN3ME20Mlg1PTR3IN88US=>NXHYZ|FoW0GQR1XS
SK-N-FIMonhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mk\VTWM2OD12Lki1NFA6KM7:TR?=NX6wOZBqW0GQR1XS
ES1NGfPVFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHOwNndKSzVyPUSuPFYxPTdizszNM3jvWnNCVkeHUh?=
SF126M2HBVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYDJR|UxRTRwOUOxPFQh|ryPNVzNTG5lW0GQR1XS
ES5MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWTTRmhuUUN3ME21MlEzPDJ5IN88US=>NUnMXm1KW0GQR1XS
LoVoNEXsfY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVLMUJhiUUN3ME21MlE2QDdzIN88US=>NYXzUHFkW0GQR1XS
SNU-387NHTkRmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF;XOGNKSzVyPUWuN|I{OzlizszNMoqwV2FPT0WU
C8166NVHtcJg4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFrXSndKSzVyPUWuN|Y{OzlizszNNW\jc5d4W0GQR1XS
LS-1034NWSyXVlCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1KzXWlEPTB;NT60NlMxPyEQvF2=NV\6PVJUW0GQR1XS
GR-STNU\TbHhvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUfFT5NSUUN3ME21MlUzOjBzIN88US=>MV3TRW5ITVJ?
NCI-H1092M4jiPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFTRUGdKSzVyPUWuO|I5PDNizszNNEDMdIhUSU6JRWK=
647-VMlzoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH3vT3pKSzVyPUWuO|Q4ODZizszNMYPTRW5ITVJ?
EW-13M3rvfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M37lVWlEPTB;NT63OlYzPyEQvF2=NF\lWFFUSU6JRWK=
KGNM1zPdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NID6TlFKSzVyPU[uNFk6OjFizszNNYXh[5F[W0GQR1XS
D-423MGNEHwW3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYXQZ2pSUUN3ME22MlQxOjh2IN88US=>M{jPbHNCVkeHUh?=
ECC10Mke4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MU\JR|UxRTdwMUCxNFEh|ryPMmfHV2FPT0WU
TE-5NUW0c|Q2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1ewRmlEPTB;Nz60NVI6QCEQvF2=NFj6Z5pUSU6JRWK=
P12-ICHIKAWANF72N2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NW\oVFlzUUN3ME23MlQ2PTJ|IN88US=>NHTkc5RUSU6JRWK=
NCI-H82NYn6RWw5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{HNbGlEPTB;Nz60OVcxOSEQvF2=M12x[HNCVkeHUh?=
NCI-H1993NX3scmNiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXzJR|UxRTdwOEOwOlMh|ryPM1HZNnNCVkeHUh?=
RH-1MkfpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFT5VZFKSzVyPUeuPFUzPDRizszNMkLpV2FPT0WU
SW948NEOzZYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoXxTWM2OD15Lkm2NFQ6KM7:TR?=NEHCV3JUSU6JRWK=
CAL-33NXLWdohNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2DQW2lEPTB;Nz65PVk{QCEQvF2=NEXrWFhUSU6JRWK=
U-266M3vudWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2HLPGlEPTB;OD6xOVc4PyEQvF2=M3jwNnNCVkeHUh?=
CAL-72MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoTDTWM2OD16LkKwN|Ih|ryPM4LkfHNCVkeHUh?=
SNU-423MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml;TTWM2OD17LkO2OlY3KM7:TR?=MojlV2FPT0WU
KG-1MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWr3OlZuUUN3ME25MlU5PDV4IN88US=>MnP4V2FPT0WU
HCC1395MmOzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NU[yXY4yUUN3ME25MlkzOzV{IN88US=>M37rbXNCVkeHUh?=
BE-13NUKz[Jp3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{S1W2lEPTB;MUCuPFg6OiEQvF2=MWDTRW5ITVJ?
MKN7NGPV[|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmPyTWM2OD1zMD65O|Y2KM7:TR?=NYK5e|N[W0GQR1XS
697M2fYZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWDyeoV1UUN3ME2xNU4yPDd{IN88US=>NHXtXW9USU6JRWK=
LU-135M1HXXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1f0TWlEPTB;MUGuNlMxPyEQvF2=Ml:3V2FPT0WU
ES7M1zJeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWeyVIpLUUN3ME2xNU4{OzF|IN88US=>MVHTRW5ITVJ?
SK-HEP-1NUPVeJJuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M33RV2lEPTB;MUGuO|Y1PiEQvF2=M3PybXNCVkeHUh?=
BENNVW1fIZGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2\yTWlEPTB;MUGuPFUyKM7:TR?=MV7TRW5ITVJ?
NCI-H1770NXyye4pvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1HTNWlEPTB;MUKuNVI3KM7:TR?=NGnKZ41USU6JRWK=
SW13MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4fBOGlEPTB;MUKuNVU1OSEQvF2=NF\KcXdUSU6JRWK=
MZ1-PCNVHOS2lmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmfxTWM2OD1zMj61OFUzKM7:TR?=NE[0ZWlUSU6JRWK=
Mo-TMUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYDMfIVzUUN3ME2xNk44PDJzIN88US=>MVPTRW5ITVJ?
HLEMn3zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoX4TWM2OD1zMj64NlE2KM7:TR?=MYfTRW5ITVJ?
RCC10RGBNH7wd2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3vHOmlEPTB;MUOuOlcyKM7:TR?=MWjTRW5ITVJ?
COLO-320-HSRM1L0Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnrwTWM2OD1zMz63N|gyKM7:TR?=M2Sx[nNCVkeHUh?=
BHT-101M1zFdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVnJR|UxRTF|LkizOFUh|ryPMofDV2FPT0WU
OCUB-MMln5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVPufVVOUUN3ME2xOE4yPjB{IN88US=>M4j5R3NCVkeHUh?=
MEG-01NH3uboFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVvk[WpTUUN3ME2xOE4{PzB6IN88US=>M3v1TXNCVkeHUh?=
RS4-11MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWLXOoJSUUN3ME2xOE44PDJizszNNFrVc4tUSU6JRWK=
MN-60NWqyW3RjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFu4ToxKSzVyPUG0Mlc5QTRizszNMXfTRW5ITVJ?
NCI-H1304NFXMXZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUXJR|UxRTF3LkC0NlUh|ryPMX3TRW5ITVJ?
Ramos-2G6-4C10NEXPXXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFrQTWVKSzVyPUG1MlA2QDFizszNM1\VOXNCVkeHUh?=
NCI-H2342M4Wx[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXfJR|UxRTF3LkKwOFQh|ryPM1jNcnNCVkeHUh?=
LAN-6NH7L[mdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmDMTWM2OD1zNT60OFE1KM7:TR?=NYT6NFY2W0GQR1XS
JVM-2NVG4WW9KT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnPHTWM2OD1zNT61O|Q5KM7:TR?=M1;XUHNCVkeHUh?=
P30-OHKM2jsNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml\VTWM2OD1zNj6wOlE1KM7:TR?=MoTCV2FPT0WU
C-33-AMVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHntOo1KSzVyPUG2MlYzOTRizszNM3n0VHNCVkeHUh?=
RPMI-8866M2iyXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmHTTWM2OD1zNj64OFk3KM7:TR?=NWSzR3NiW0GQR1XS
NCI-H630Mom1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEPadVRKSzVyPUG2Mlg2OzdizszNNHHxfHJUSU6JRWK=
KYSE-140MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEnTT|FKSzVyPUG3MlIxOjhizszNM1jt[HNCVkeHUh?=
T84NFnZOXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIfLVXhKSzVyPUG4Mlg3QTVizszNNVvRbXpuW0GQR1XS
KU-19-19MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWPJR|UxRTF6Lkm2NFgh|ryPM1LOOXNCVkeHUh?=
BALL-1M4XMTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV\qXo9vUUN3ME2xPU4{Ozl7IN88US=>M3zNXnNCVkeHUh?=
Calu-6M{L1[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mle0TWM2OD1zOT60PVIh|ryPMmL6V2FPT0WU
EGI-1Mnu5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEjlPXJKSzVyPUG5MlU6QCEQvF2=MlT4V2FPT0WU
MFH-inoMUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHPQS2FKSzVyPUG5Mlc1PTRizszNNF7UbFRUSU6JRWK=
GB-1MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHXQPFRKSzVyPUKwMlM2OzVizszNMlvrV2FPT0WU
NCI-H1693NVToRYpwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{Ts[WlEPTB;MkCuOlUxPSEQvF2=M2DIUHNCVkeHUh?=
SW1116NVLEXm5yT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHfjSW5KSzVyPUKwMlk{PjJizszNNFX5Z2NUSU6JRWK=
H-EMC-SSM1u3bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFHYNIlKSzVyPUKyMlA1PSEQvF2=NGnTZ3pUSU6JRWK=
D-502MGNG\w[3dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYPJR|UxRTJ{LkiyOlEh|ryPM3v0V3NCVkeHUh?=
IA-LMMX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIjF[WxKSzVyPUKzMlI1QTNizszNNEeweXJUSU6JRWK=
SW1463NH:0TVZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoLiTWM2OD1{Mz63PUDPxE1?NULRfow4W0GQR1XS
JARNWjifWJKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlTrTWM2OD1{ND6zNlk{KM7:TR?=M{TCOnNCVkeHUh?=
HTNUXaNYhqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXrJR|UxRTJ2LkS3OVMh|ryPMl3kV2FPT0WU
LCLC-103HNX\FNIYxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWHJR|UxRTJ2Lki0OFkh|ryPMkW4V2FPT0WU
SNU-449MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYXJR|UxRTJ2Lki3OFEh|ryPM4mxZnNCVkeHUh?=
KE-37MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4LQfWlEPTB;MkWuNFkzQCEQvF2=M2PhSnNCVkeHUh?=
NCI-H1623MlGzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYDJR|UxRTJ5LkGzNFMh|ryPMVHTRW5ITVJ?
MOLT-13NH3zUmdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2HxW2lEPTB;MkeuN|UyPiEQvF2=MoXsV2FPT0WU
COLO-741NFzBV2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHKzfnNKSzVyPUOxMlM{OzNizszNMV;TRW5ITVJ?
NB6NYPWeIJuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHnJS4JKSzVyPUOyMlI5PzZizszNMmWxV2FPT0WU
MOLT-16MnTES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIKzcmhKSzVyPUOzMlAxPTVizszNNV7TbZd2W0GQR1XS
IST-MES1MkTPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXHJR|UxRTN2LkC1OFEh|ryPNXnrT5ZiW0GQR1XS
A4-FukM{HCbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnTsTWM2OD1|NT6wOlYh|ryPMkP0V2FPT0WU
CAL-85-1MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV7tXmFQUUN3ME2zOU4zQDF5IN88US=>M{\EdHNCVkeHUh?=
CCRF-CEMNGriW25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4q4[2lEPTB;M{euNVU{PiEQvF2=M3vFPHNCVkeHUh?=
HAL-01NWTBfnM1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGPWbXFKSzVyPUO4MlQ5QDlizszNMnPNV2FPT0WU
HELNIO4PJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2n4R2lEPTB;NEOuN|QxQSEQvF2=NXLyfVl3W0GQR1XS
EW-1M1nZfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4jFbWlEPTB;NEOuOFc3QCEQvF2=NYX4W2g6W0GQR1XS
MDA-MB-231MnzRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3vDUGlEPTB;NEWuNVE6QSEQvF2=NFnIfYpUSU6JRWK=
ABC-1M{j4UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlzsTWM2OD12Nj64OVM5KM7:TR?=NInIN5ZUSU6JRWK=
NCI-H446MlLYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1\E[mlEPTB;NEiuOVA2QCEQvF2=NFTuVnFUSU6JRWK=
MHH-PREB-1NVrze|J3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX;JR|UxRTR7Lk[wNFch|ryPMl23V2FPT0WU
DOHH-2NIH2PW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYfJR|UxRTR7Lk[2OVYh|ryPMVXTRW5ITVJ?
GCTM335eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXTa[HFPUUN3ME20PU43QTd4IN88US=>NGXwZXpUSU6JRWK=

... Click to View More Cell Line Experimental Data

In vivo 17-AAG displays significantly higher binding affinity for Hsp90 from 3T3-src, B16 or CT26 xenografts in nude mice with IC50 values of 8-35 nM as compared with that from the normal tissues with IC50 values of 200-600 nM. [1] Administration of 17-AAG (~50 mg/kg) causes significant decline in AR, HER2, HER3, and Akt expression in a dose-dependent manner with >50% decline at dose of 50 mg/kg, resulting in the dose-dependent inhibition of androgen-dependent (CWR22) and -independent (CWR22R and CWRSA6) prostate cancer xenografts growth by 67%, 80% and 68% at dose of 50 mg/kg, respectively. [2]
Features Displays very low toxicity toward normal cells.

Protocol(Only for Reference)

Kinase Assay: [1]

Hsp90 binding assays Purified native Hsp90 protein or cell lysates from HER-2-overexpressing cancer cells (BT474, N87, SKOV3 and SKBR3) or BT474 breast carcinoma cells in lysis buffer (20 mM HEPES, pH 7.3, 1 mM EDTA, 5 mM MgCl2, 100 mM KCl) are incubated with various concentrations of 17-AAG for 30 minutes at 4 °C, and then incubated with biotin-GM linked to BioMag streptavidin magnetic beads for 1 hour at 4 °C. Tubes are placed on a magnetic rack, and the unbound supernatant removed. The magnetic beads are washed three times in lysis buffer and heated for 5 minutes at 95 °C in SDS–PAGE sample buffer. Samples are analysed on SDS protein gels, and western blots done using indicated antibodies. Bands in the western blots are quantified using the Bio-rad Fluor-S MultiImager, and the percentage inhibition of binding of Hsp90 to the biotin-GM is calculated. The IC50 reported is the concentration of 17-AAG needed to cause half-maximal inhibition of binding.

Cell Assay: [1]

Cell lines BT474, SKBR3, N87, SKOV3, MCF7, MDA468, Hs578T, Hs578Bst, A549, HT29, U87, SKMG3, HT1080, RPTEC, NDF, HMVEC, HMEC, HUVEC, and PBMC cells
Concentrations Dissolved in DMSO, final concentrations ~10 μM
Incubation Time 5 days
Method Cells are seeded in 96-well plates at 2,000 cells per well in a final culture volume of 100 μL for 24 hours before the addition of increasing concentrations of 17-AAG that is incubated for 5 days. Viable cell number is determined using the Celltiter 96 AQueous Nonradioactive Cell Proliferation Assay. The value of the background absorbance at 490 nm (A490) of wells not containing cells is subtracted. Percentage of viable cells = (A490 of 17-AAG treated sample/A490 untreated cells) × 100. The IC50 is defined as the concentration that gave rise to 50% viable cell number.

Animal Study: [2]

Animal Models Male nu/nu athymic mice inoculated s.c. with androgen-dependent CWR22 xenograft, and female nu/nu athymic mice inoculated s.c. with androgen-independent xenografts CWR22R and CWRSA6
Formulation Dissolved in DMSO, and diluted in egg phospholipids (EPL) vehicle
Dosages ~50 mg/kg
Administration Injection i.p.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Kamal A, et al. Nature, 2003, 425(6956), 407-410.

[2] Solit DB, et al. Clin Cancer Res, 2002, 8(5), 986-993.

view more

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-07-30)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT00577889 Completed Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic Cancer National Cancer Institute (NCI) March 2008 Phase 2
NCT00546780 Completed Multiple Myeloma Bristol-Myers Squibb February 2008 Phase 3
NCT00093496 Completed Primary Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer National Cancer Institute (NCI) October 2007 Phase 2
NCT00514371 Completed Multiple Myeloma Bristol-Myers Squibb August 2007 Phase 2|Phase 3
NCT00779428 Completed Advanced Malignancies Bristol-Myers Squibb July 2006 Phase 2

view more

Chemical Information

Download 17-AAG (Tanespimycin) SDF
Molecular Weight (MW) 585.69
Formula

C31H43N3O8

CAS No. 75747-14-7
Storage 3 years -20℃powder
2 years -80℃in solvent
Synonyms CP127374,NSC-330507, KOS 953
Solubility (25°C) * In vitro DMSO 100 mg/mL (170.73 mM)
Ethanol 5 mg/mL (8.53 mM)
Water <1 mg/mL
In vivo
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 17-demethoxy-17-(2-propenylamino)- [(3R,5R,6S,7R,8E,10R,11R,12Z,14E)-6-Hydroxy-5,11,21-trimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate

Frequently Asked Questions

  • Question 1
    What kind of subtypes does this compound inhibit? HSP90α or HSP90β ?

    Answer: 17-AAG can inhibit both HSP90α and HSP90β, but it is unclear how much are they affected respectively. You should note that Hsp90 derived from tumor cells has a 100-fold higher binding affinity for 17-AAG than that from normal cells according to this paper. http://www.nature.com.ezp-prod1.hul.harvard.edu/nature/journal/v425/n6956/full/nature01913.html

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related HSP (e.g. HSP90) Products

  • PU-H71

    PU-H71 is a potent and selective inhibitor of HSP90 with IC50 of 51 nM. Phase 1.

  • KNK437

    KNK437 is a pan-HSP inhibitor, which inhibits the synthesis of inducible HSPs, including HSP105, HSP72, and HSP40.

  • VER155008

    VER-155008 is a potent Hsp70 family inhibitor with IC50 of 0.5 μM, 2.6 μM, and 2.6 μM in cell-free assays for HSP70, HSC70, and GRP78, respectively, >100-fold selectivity over HSP90.

  • Luminespib (AUY-922, NVP-AUY922)

    Luminespib (AUY-922, NVP-AUY922) is a highly potent HSP90 inhibitor for HSP90α/β with IC50 of 13 nM /21 nM in cell-free assays, weaker potency against the HSP90 family members GRP94 and TRAP-1, exhibits the tightest binding of any small-molecule HSP90 ligand. Phase 2.

  • Ganetespib (STA-9090)

    Ganetespib (STA-9090) is an HSP90 inhibitor with IC50 of 4 nM in OSA 8 cells, induces apoptosis of OSA cells while normal osteoblasts are not affected; active metabolite of STA-1474. Phase 3.

  • 17-DMAG (Alvespimycin) HCl

    17-DMAG (Alvespimycin) HCl is a potent HSP90 inhibitor with IC50 of 62 nM in a cell-free assay. Phase 2.

    Features:A synthetic derivative Geldanamycin, with lower hepatotoxicity than parent antibiotic & higher potency and bioavailability than the similar derivative 17-AAG.

  • Geldanamycin

    Geldanamycin is a natural existing HSP90 inhibitor with Kd of 1.2 μM, specifically disrupts glucocorticoid receptor (GR)/HSP association.

  • HSP990 (NVP-HSP990)

    NVP-HSP990 (HSP990) is a novel, potent and selective HSP90 inhibitor for HSP90α/β with IC50 of 0.6 nM/0.8 nM.

    Features:NVP-HSP990 is an orally available HSP90 inhibitor and is structurally distinct from other clinical HSP90 inhibitors.

  • Elesclomol (STA-4783)

    Elesclomol (STA-4783) is a novel potent oxidative stress inducer that elicits pro-apoptosis events among tumor cells. Phase 3.

  • Onalespib (AT13387)

    Onalespib (AT13387) is a selective potent Hsp90 inhibitor with IC50 of 18 nM in A375 cells, displays a long duration of anti-tumor activity. Phase 2.

Recently Viewed Items

Tags: buy 17-AAG (Tanespimycin) | 17-AAG (Tanespimycin) supplier | purchase 17-AAG (Tanespimycin) | 17-AAG (Tanespimycin) cost | 17-AAG (Tanespimycin) manufacturer | order 17-AAG (Tanespimycin) | 17-AAG (Tanespimycin) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us